| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antipsychotic drugs and relapse prevention
|
Marder, Stephen R
|
|
1999
|
35 |
S1 |
p. S87-S92
6 p.
|
article
|
| 2 |
Anxious–depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy?
|
Tollefson, Gary D.
|
|
1999
|
35 |
S1 |
p. S13-S21
9 p.
|
article
|
| 3 |
Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns
|
Volavka, Jan
|
|
1999
|
35 |
S1 |
p. S23-S33
11 p.
|
article
|
| 4 |
Cognitive improvement in schizophrenia with novel antipsychotic medications
|
Purdon, Scot E.
|
|
1999
|
35 |
S1 |
p. S51-S60
10 p.
|
article
|
| 5 |
Discussion
|
|
|
1999
|
35 |
S1 |
p. S3-S4
2 p.
|
article
|
| 6 |
Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes
|
Dixon, Lisa
|
|
1999
|
35 |
S1 |
p. S93-S100
8 p.
|
article
|
| 7 |
Neuroleptic-induced hyperprolactinemia
|
Dickson, Ruth A.
|
|
1999
|
35 |
S1 |
p. S75-S86
12 p.
|
article
|
| 8 |
Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia
|
Revicki, Dennis A
|
|
1999
|
35 |
S1 |
p. S101-S109
9 p.
|
article
|
| 9 |
Prolactin and antipsychotic medications: mechanism of action
|
Petty, Richard G.
|
|
1999
|
35 |
S1 |
p. S67-S73
7 p.
|
article
|
| 10 |
Schizoaffective disorder: role of atypical antipsychotics
|
Keck Jr., Paul E.
|
|
1999
|
35 |
S1 |
p. S5-S12
8 p.
|
article
|
| 11 |
Tardive dyskinesia and atypical antipsychotic drugs
|
Casey, Daniel E.
|
|
1999
|
35 |
S1 |
p. S61-S66
6 p.
|
article
|
| 12 |
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients
|
Krystal, John H
|
|
1999
|
35 |
S1 |
p. S35-S49
15 p.
|
article
|
Journal description